Ipsen S.A.
Ipsen S.A. (IPSEY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IPSEY · as of Jun 8, 2026
Key Statistics
Explore Ipsen S.A. Data
ipsey stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
Competitors & Peers
ipsey competitorsIPSEY
CHALF
DSKYF
DSNKY
HLNCF
HOCPFStock Performance
Full HistoryAbout Ipsen S.A.
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Som…
what is ipsen s.a. · ipsey stock overview · ipsen s.a. company profile · who is ipsen s.a. ceo · ipsey OTC · ipsen s.a. headquarters · ipsen s.a. business segments
About Stock Overview & Key Data
Ipsen S.A. (IPSEY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Aug 3, 2012. As of the latest trading session, IPSEY stock price is $46.75, with a market capitalization of $61.8B. The stock has returned +57.14% over the past 12 months and +28.58% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Ipsen S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Ipsen S.A. reported revenue of $3.5B and net income of $427.0M. For detailed data — including Ipsen S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ipsen S.A. (IPSEY) stock price is $46.75. The stock is traded on OTC under the ticker symbol IPSEY. The 52-week range is $28.66 – $51.10.